Liposomes Market Research Report - Forecast 2017 – 2025
Liposomes can be divided into two categories on the basis of their size and the number of bilayers – unilamellar vesicles and multilamellar vesicles. Unilamellar vesicles-aqueous solution is enclosed within vesicles having single phospholipid bilayer sphere. Unilamellar vesicles are further divided into Large Unilamellar Vesicles (LUV) and Small Unilamellar Vesicles (SUV). On the other hand, several unilamellar structures collectively make a multilamellar structure of concentric phospholipid spheres separated by layers of water. Multilamellar Vesicles look like an onion.
Water soluble drugs are encapsulated by vesicles in their aqueous spaces and lipid soluble drugs within the membrane. Liposomes are biodegradable, versatile and hypoallergenic in nature. There are two methods for the production of liposomes. Liposomes can be created using cholesterol and non –toxic phospholipids using two techniques:
Passive Loading Technique
Mechanical Dispersion Method
Detergent Removal Method
Solvent Dispersion Method
Active loading Technique
Request to Browse Full Table of Content, figure and Tables @ https://www.persistencemarketresearch.com/toc/16546
Liposomes provide selective passive targeting to tumor tissues and are used as carriers for increased and sustained drug delivery. However, once administered, liposomes cannot be removed. Leakage of encapsulated drug during storage is another problem associated with their use.
Liposomes are mainly used for controlled and targeted drug delivery in pharmaceutical industries. Within the cosmetics industry, they are used as carriers for many molecules. Liposomes may differ depending on their lipid size, composition, surface charge and method of preparation. They are biodegradable and biocompatible and are able to trap both hyrophillic and lipophilic drugs. Liposomes may be very small (0.025 μm) or very large ((2.5 μm) vesicles.
Liposomes: Market Dynamics
Liposomes are used in the treatment of solid tumors. Liposomes containing bisphosphonates target solid tumors and reduce tumor associated macrophages. It is also expected that the market for liposomes will grow as the demand for effective drugs in the field of pharmaceuticals is expected to increase over the forecast period.
Increase in the number of patients and strict government policies are expected to improve liposomes market. Improvement in healthcare facilities and advancements in technology will also positively affect the liposomes market.
Increasing awareness among people and increase in diseases have fueled the use of drugs containing liposomes. At the same time, innovation of products with better efficiency has also led to increased consumption of drugs containing liposomes. Collaborations with companies and popularity of liposome-containing drugs is also expected to create new opportunities in the market.
Liposomes target the disease cells at disease sites. Not just that, they also have low toxicity. Due to these properties, liposomes are achieving clinical acceptance and the liposomes market is thus, expected to grow at a healthy pace during the forecast period.
Request Sample Report @ https://www.persistencemarketresearch.com/samples/16546
Liposomes: Regional Outlook
Increasing population and a rise in the number of diseases are the two factors expected to cause the Liposome market to grow in the Asia Pacific region as it is important to find the cure of diseases. Increasing pharmaceutical applications and easy availability of products are also expected to aid the growth of the liposomes market in the Asia Pacific Region.
The U.S. & Europe markets are expected to grow as advancements in technology are leading to research on various successful methods to cure diseases. The growth of Liposomes market is expected to gear up due to the growing applications of liposomes in gene therapy, drug delivery, specific targeting, drug protection, etc. across the globe.
Liposomes: Market Participants
Some of the market giants in the global Liposomes market are:
Shanghai New Asia
Johnson & Johnson
Encapsula Nano Sciences
Pre Book Full Report @ https://www.persistencemarketresearch.com/checkout/16546
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liposomes Market Research Report - Forecast 2017 – 2025 here
News-ID: 897380 • Views: 149
More Releases from Persistence Market Research
The Fta Buccal Collection Kits Market to be bolstered by technology
FTA buccal collection kits is used in the collection and analysis of DNA most commonly from the buccal cells or blood. Collection of buccal samples through FTA cards are painless and relatively easily collected, are often preferred source. There are several buccal collection methods such as brushes, swabs, FTA or IsoCode cards. Among all, FTA cards mostly used methods, and this is due to FTA card produce DNA that
The Syringeless Based Filters Market to reap the benefits of technology in the n …
A syringeless based filter offers an easier, faster method of removing particulates from samples being prepared for high-performance liquid chromatography (HPLC) analysis. Moreover, that syringeless based filter can add up the money savings, plus the time saved from cutting multiple consumables out of the sample preparation process. Syringeless based filters serve the rapid single step procedure, due to which sample loss is reduced. A shrill trend in the application of
The Whatman Indicating Mini Cards Market to identify its growth parameters betwe …
Whatman indicating mini cards offers a system through which simplifying the purification, isolation and storage of nucleic acids is possible in a variety of research and diagnostic operations. Additionally, whatman indicating mini cards market has simplifies the processing and handling of nucleic acids with a wide range of applications. It is based on the chemicals, present on whatman indicating mini cards which can denature proteins, lyse cells and protect nucleic
The Pediatric Respiratory Devices Market to witness livewire performance between …
Pediatric respiratory devices diagnose diseases and conditions from birth through age 21. Pediatric subpopulations are categories as neonates, infants, children and adolescent. Recently, the Food and Drug Administration (FDA) of the United States has been focusing on “Unmet Medical Needs” in the pediatric patients and orphan diseases, and policies to protect pediatric patients in clinical trials for medical devices have been established and reinforced. For instance, vessel sealing devices jejunal
More Releases for Liposome
Injectable Nanomedicines Market Poised to Witness Strong Revenue Growth, as Lipo …
The growth of the injectable nanomedicines market is attributed to the growing use of liposomal drugs and increase in treatment seeking population across the globe. According to a latest research by the company, the global liposomes market is expected to account for revenues over US$ 300 Mn in terms of value by 2026 end. Injectable nanomedicines market is expected to witness significant growth with CAGR pegged at 8.1% through 2026.
Global Nanoemulsion Market 2018: Covaris, Inc, LATITUDE Pharmaceuticals Inc., Ta …
Small size and high advantages of nanoemulsion allow for multiple applications in pharmaceuticals, creating significant growth opportunity for pharma companies. Nanoemulsions allow for small and slow administration of oral drugs and assure the complete absorption of drugs and reduce dose related toxicity. Various studies have been carried out to explore other avenues of drug delivery using nanoemulsion. In 2009, a study conducted in National Research Center, Dokki, Cairo, Egypt concluded
Liposome in Cosmetics Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Liposome in Cosmetics market. Liposomes are spherical vesicles in which their central aqueous section is surrounded by one or more of a bilayer membrane (Lamella) that is frequently enclosed by aquatic environments. These vesicles are formed when amphiphilic lipids confront with aqueous milieu. They can vary in size from 15 nm to several microns. In the
Liposome in Cosmetics Industry Analysis by 2025: QY Research
In its recently published report, QY Research has provided unique insights about global Liposome in Cosmetics market for the given period. One of the main objectives of this report is to categorize the various dynamics of the market and to offer latest updates such as mergers and acquisitions, various technological developments, new entrants in the market, which make an impact on different segments of the global Liposome in Cosmetics market. The scope of
Global Liposome Drug Delivery Market
The “Global Liposome Drug Delivery Market” is an in depth study analyzing the current state and forecast 2018-2025. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Global Liposome Drug Delivery Market provides analysis of market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in market,
Rectal Cancer Therapeutics Pipeline Review 2018 - Taiwan Liposome Company, Sanof …
According to the research findings, most of the drug candidates for the treatment of rectal cancer are being developed to be administered by the intravenous and the oral route. The main advantage associated with the intravenous route is that the drug can easily be entered the bloodstream, or lymph vessels. Also, medication can be easy to take through the oral route, additionally the route has very less patient non-compliance. Browse report